Serum Triglyceride Levels and Cardiovascular Disease Events in Koreans

Eun Hee Kim1, Jung Bok Lee, Seon Ha Kim

  • 1Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Cardiology
|May 14, 2015
PubMed

Insights

High triglyceride levels significantly increase cardiovascular disease (CVD) risk, particularly in individuals without obesity, hypertension, or diabetes. This finding highlights hypertriglyceridemia as an independent CVD risk factor.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Epidemiology

Background:

  • Elevated LDL-cholesterol is a known cardiovascular disease (CVD) risk factor.
  • The role of triglycerides in CVD risk is debated.
  • Hypertriglyceridemia requires further investigation as an independent risk factor.

Purpose of the Study:

  • To investigate the association between triglyceride levels and CVD risk.
  • To determine if hypertriglyceridemia is an independent risk factor for CVD.
  • To analyze CVD risk associated with triglycerides in specific subgroups.

Main Methods:

  • A cohort of 76,434 participants was analyzed from health checkup data.
  • Cardiovascular events and mortality were tracked using national health insurance claims and death certificates.
  • Statistical analysis included age- and sex-adjusted odds ratios and multivariate risk factor adjustments.

Main Results:

  • Higher triglyceride levels were associated with significantly increased odds of major CVD events (OR 1.52) and overall CVD events (OR 1.49).
  • This association remained significant after adjusting for HDL-cholesterol and other risk factors.
  • The increased CVD risk associated with high triglycerides was pronounced in nonobese, normotensive, and nondiabetic individuals.

Conclusions:

  • Hypertriglyceridemia is an independent risk factor for cardiovascular disease.
  • The association between high triglycerides and CVD is particularly strong in individuals without other major risk factors.
  • Managing triglyceride levels may be crucial for CVD prevention, especially in specific patient populations.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
871
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
781
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
866
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
585
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602